Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Abacavir1件: Abacavir1件: D07057 --4件: 2, 135, 265, 325
2Baricitinib1件: Baricitinib1件: D10308 2件: JAK1,
JAK2 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬13件: 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325
3Emtricitabine1件: Emtricitabine1件: D01199 --4件: 25, 93, 265, 325
4Lamivudine1件: Lamivudine1件: D00353 --7件: 2, 26, 42, 46, 135, 265, 325
5LY3009104----6件: 46, 49, 50, 93, 107, 325
6Reverse transcriptase inhibitors: Zidovudine, Lamivudine, Abacavir3件: Abacavir,
Lamivudine,
Zidovudine		3件: D00353 ,
D00413 ,
D07057 		--1件: 325
7Tenofovir1件: Tenofovir disoproxil---6件: 2, 13, 25, 93, 265, 325
8Tenofovir (TDF) and Emtricitabine (FTC)2件: Emtricitabine,
Tenofovir		2件: D01199 ,
D06074 		--1件: 325
9TPN-101----3件: 2, 127, 325
10Zidovudine1件: Zidovudine1件: D00413 --6件: 25, 26, 135, 265, 325, 331